bluebird bio
3,549
$61.029876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$61.02
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.02 (-0.03%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell bluebird bio and other stocks, options, ETFs, and crypto commission-free!
About BLUE
bluebird bio, Inc. Common Stock, also called bluebird bio, is a clinical-stage biotechnology company, which engages in the development of potential gene therapies for severe genetic diseases and cancer. Read More Its integrated product platform includes gene therapy, cancer immunotherapy, and gene editing. Its product pipeline includes Lenti-D, LentiGlobin, BCL11a shRNA, bb2121, and bb21217. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Cambridge, MA.
CEO
Employees
1,090
Headquarters
Cambridge, Massachusetts
Founded
1992
Market Cap
3.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.29M
High Today
$62.40
Low Today
$60.27
Open Price
$61.09
Volume
1.04M
52 Week High
$143.98
52 Week Low
$38.95
Collections
Analyst Ratings
77%
of 22 ratings
Buy
77%
Hold
23%
Sell
0%
BLUE Earnings
-$4.04
-$2.69
-$1.35
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Jul 30, Pre-Market